Articles tagged with Cancer Medication
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Scientists at Scripps Research Institute have successfully disrupted MYC, a cancer regulator thought to be undruggable, using a credit card-like molecule called KJ-Pyr-9. This breakthrough discovery shows the drug candidate can stop tumor growth in animal models and may offer new hope for cancer treatment.
A new study led by researchers at UCSF analyzed the effect of two widely used osteoporosis drugs on breast cancer risk in post-menopausal women. The findings suggest that low estrogen levels, rather than the drugs themselves, may be protecting against breast cancer.
Researchers have discovered how a drug that starves cancer cells of an essential amino acid kills them. The study's findings suggest using this approach may spare patients from chemotherapy toxicity.
A study published in the New England Journal of Medicine found that women with mutations in the PALB2 gene have a one in three chance of developing breast cancer by age 70. The study analyzed data from 154 families and found that risks were higher for those with family history of breast cancer.
A new £6 million initiative is being launched to support cutting-edge research on cancer prevention. The project aims to build capacity in prevention science, combining lifestyle changes and interdisciplinary collaboration to reduce cancer cases.
The prostate cancer risk calculator has been updated to provide a more nuanced result, helping men understand their risk of low-grade and high-grade prostate cancer. The new calculator incorporates current risk factors and an advanced statistical model to distinguish between the prediction of low-grade and high-grade disease.
Researchers at Cancer Research UK have found a new use for an old drug, rapamycin, in shrinking and stopping the spread of a specific type of pancreatic cancer tumour. The study suggests that targeting mTOR dependency may be a key to tailoring treatment to individual patients.
A study found that retinoblastoma protein is less active in male brain cells, leading to higher brain tumor rates and poorer survival rates. The researchers believe this discovery could lead to more effective therapies and treatments.
University of Michigan researchers identified a protein called TRIP13 that enables cancer cells to repair themselves and survive despite chemotherapy. The team found an existing chemical compound that can block this process, potentially increasing the effectiveness of cancer treatment and improving patient survival rates.
Scientists at Barts Cancer Institute have identified a molecule called focal adhesion kinase (FAK) that signals the body to repair itself after chemotherapy or radiotherapy. Removing FAK from blood vessels in melanoma and lung cancer models made treatments more effective, suggesting that targeting this molecule could boost cancer therapy.
Researchers identified a core signalling system, the hippo pathway, and discovered how Merlin suppresses it within the nucleus. This understanding paves the way for developing effective drug therapies to treat nervous system tumours.
Researchers reveal detailed images of anaphase-promoting complex (APC/C), a protein that controls mitosis. The discovery could lead to new cancer drugs by identifying binding sites for future treatments.
A study has identified over 27,000 endogenous retroviruses preserved in the genomes of 38 mammal species, including humans. Larger animals have fewer ERVs, suggesting they may have evolved mechanisms to combat cancer-causing mutations.
A decade of research led by Dr. Tak Mak identified PLK4 as a promising therapeutic target for breast cancer treatment and developed a small molecule inhibitor to block it. The study showed significant antitumor activity in preclinical models, offering hope for personalized cancer medicine.
A new skin gel form of tamoxifen has been developed and tested on women with non-invasive breast cancer, reducing cancer cell growth while minimizing side effects. The gel application was found to be effective in reducing blood clot risk associated with oral tamoxifen, offering a safer treatment option.
A*STAR's Bioprocessing Technology Institute has partnered with Roche to develop new cancer treatments using novel antibodies that can directly target and destroy cancer cells. The partnership aims to improve cancer detection and treatment, offering a potential breakthrough in cancer therapy.
The foundation has granted over $3.3 million to support the research of 16 early-career investigators pursuing novel ideas in cancer research. The recipients will focus on developing new treatments and understanding the underlying mechanisms of various types of cancers.
Researchers isolated breast cancer cells from patients' blood and expanded them in the lab, identifying new mutations and drug susceptibility. The study found a promising drug, Ganetspib, effective in killing tumor cells with specific genetic mutations.
Researchers at Massachusetts General Hospital developed a microchip-based device to capture and culture circulating tumor cells (CTCs) for genetic analysis and drug testing. The study found that cultured CTCs accurately reflect a tumor's genetic mutation over time, revealing new mutations and potential drug targets.
Researchers at the University of Manchester discovered a new drug, AZD3965, effective in treating small cell lung cancer. The treatment approach exploits the change in energy production in tumours, targeting monocarboxylate transporters involved in lactate movement.
A drug candidate developed to treat sickle cell disease has been acquired by Baxter International, advancing its clinical development activities. Aes-103 significantly reduces patients' pain in Phase II clinical trials, offering a potential breakthrough treatment.
Researchers at Rockefeller University have identified a protein called TARBP2 that triggers breast cancer's spread by blocking other proteins linked to neurodegeneration. This finding suggests new cancer therapies targeting this 'master regulator' could be effective.
A study by UT Southwestern found a five-fold increase in cancer patients using MyChart from 2009 to 2015, with those over 60 making up the majority of frequent users. The technology's convenience and ease of use contribute to its widespread adoption among this demographic.
Researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors. These genetic changes may expand treatments for patients, as drugs targeting some of these pathways are already available or in clinical trials.
A study found that genetic mutations in liver cells drive tumor formation in iCCA, with mutant proteins impairing liver cell development and increasing the risk of metastasis. Researchers discovered a potential treatment option by targeting IDH1/2 mutations, opening a new line of investigation for biomarkers and life-saving decisions.
A new study published in PNAS found that metabolic processes are significantly increased during sleep deprivation, with 27 metabolites found at higher levels. This discovery could be crucial when looking at the best time of day to test for diseases such as cancer and heart disease.
A phase 3 study of everolimus failed to improve overall survival in patients with advanced hepatocellular carcinoma, a type of liver cancer. In contrast, sorafenib is the only systemic therapy shown to significantly improve overall survival.
The EORTC presents a European solution for effective cancer drug development through collaborative molecular screening platforms. These platforms enable efficient access to new therapeutic agents and adapt clinical research to individual patient needs.
Researchers at H. Lee Moffitt Cancer Center & Research Institute developed a liquid chromatography-multiple reaction monitoring mass spectrometry assay to analyze biomarkers in blood and tissue, helping identify therapeutic targets for melanoma treatment. The study identified alterations in cell signaling pathways in drug-resistant cells.
Scientists have discovered where microtubules form inside the mitotic spindle and how their starting points are transported to opposite poles. This breakthrough provides a better understanding of cell division and paves the way for more effective cancer treatments.
A recent study published in Annals of Internal Medicine found that current standard medical guidelines for childhood cancer survivors can be reduced, saving large cost-savings and little reduction in overall quality of patient care. The study suggests that screenings can be safely done cost-effectively and improve the quantity of patie...
A study by Wake Forest Baptist Medical Center found that St. John's wort use was associated with 28% of potentially harmful combinations in analyzed data. The herbal supplement can reduce the effectiveness of various medications, leading to impaired treatment outcomes and increased risk of conditions like serotonin syndrome.
A 30-year follow-up study found no link between fertility drugs and breast, ovarian, and uterine cancers, except for extended use of clomiphene citrate. The study of 12,193 women treated for infertility showed a higher risk of invasive breast cancer with clomiphene use in 12 or more treatment cycles.
A new study found that HIV-infected people diagnosed with early-stage cancer are two to four times more likely to receive inadequate treatment. The research suggests that a lack of clinical trial data and guidelines on treating HIV patients with cancer may contribute to this disparity.
Adding cetuximab or bevacizumab to combination chemotherapy improves survival for patients with KRAS wild-type untreated colorectal cancer, with both treatments offering approximately 30-month overall survival. Genetic testing is crucial to determine the benefit of these treatments.
Researchers discover synthetic triterpenoids suppress colon cancer onset by impeding inflammation and increasing 15-hydroxyprostaglandin dehydrogenase gene expression. Oral administration in mice shows promise for chemoprevention, with potential to delay or halt colon cancer development.
Researchers have discovered a partnership between MYC and non-coding RNA PVT1 that fuels cancer cells. This finding could lead to the development of drugs targeting PVT1, potentially controlling major cancer genes like MYC.
Researchers developed a hydrogel that releases chemotherapy drugs in short bursts triggered by ultrasound, improving cancer treatment outcomes. The self-healing gel approach offers a more effective and minimally invasive method for delivering drugs at the right place and time.
Saint Louis University researchers have discovered a molecular pathway that causes painful chemotherapy side effects and found a potential way to block it. A drug already approved for treating multiple sclerosis may also alleviate chemotherapy-induced peripheral neuropathy (CIPN) without affecting the medication's anticancer properties.
Early exposure to ultraviolet radiation from indoor tanning increases the risk of basal cell carcinomas in young people. Researchers found that teens and young adults who use indoor tanning devices are more likely to develop BCC, especially on the torso.
Supercomputer simulations reveal that Ras protein clusters warp cell membranes, leading researchers to investigate the design of new anticancer drugs. The study uses coarse-grained molecular dynamics simulations to understand the dynamics of Ras proteins and their interaction with the membrane.
A new tool, COST (COmprehensive Score for financial Toxicity), measures a patient's risk for and ability to tolerate financial stress in cancer care. The study found that financial toxicity affects 30% of cancer survivors, with significant impact on workability and quality of life.
Researchers discovered a genetic partnership between KRAS and YAP1, enabling cancer cells to survive in the absence of KRAS. This 'escape mechanism' must be blocked alongside shutting down oncogene KRAS to kill tumor cells.
Researchers at St. Joseph's Hospital and Medical Center discovered a new treatment for ovarian cancer that improves response rates and prolongs time until cancer recurrence. Trebananib, a peptide-Fc fusion protein, targets angiogenesis by inhibiting angiopoietin 1 and 2 binding to the Tie2 receptor.
Researchers developed a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, reprogramming these intractable cancers. The vaccine, GVAX, consists of irradiated tumor cells modified to recruit immune cells, and boosted activity of molecular mechanisms that inhibit cancer-fighting immune cells.
A study of over 56,000 patients with inflammatory bowel disease found no association between TNF inhibitor use and increased cancer risk. However, the authors emphasize the need for continued long-term follow-up to monitor potential risks.
Researchers are testing the safety and effectiveness of AG-120, a new drug designed for patients with IDH1 gene mutations, in a clinical trial at the Virginia G. Piper Cancer Center Clinical Trials. The study aims to improve treatment options for patients with solid tumors, including brain tumors and gallbladder bile duct cancer.
A meta-analysis of 43 studies found that sedentary behavior increases the risk of colon, endometrial, and lung cancers. The risk increases with sitting time, even among physically active individuals, suggesting a detrimental impact on cancer prevention.
Researchers discovered that switching off and then reactivating the Pax5 gene can reverse cancer in a common childhood leukemia model. Restoring its function enables normal blood cell development and cures the disease. The findings offer a promising new strategy for treating leukemia with fewer side effects.
Researchers at Georgetown University Medical Center found that combining tamoxifen with hydroxychloroquine reverses resistance to the breast cancer drug in mice. The study's findings provide a promising new treatment option for women with advanced estrogen receptor-positive breast cancer.
Researchers at Case Western Reserve University found that existing cancer treatment bortezomib increases levels of the vascular-protective gene KLF2, preventing blood clot formation. This discovery has potential implications for managing thrombosis in patients with predispositions to clot formation.
A class of leukemia drug has been found to stimulate immunity against multiple cancer types. Inhibiting the p110δ enzyme helps boost the body's immune system to kill tumor cells.
A new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist current treatments. The agents deliver two types of payloads directly to cancer cells, resulting in direct imaging or treatment.
Mayo Clinic researchers have identified a new form of cancer caused by a chromosomal chimera, characterized by a biphenotypic sinonasal sarcoma. The rare tumor typically begins in the nose and may require disfiguring surgery to treat.
Researchers found an association between decreased carbohydrate intake and reduced breast cancer recurrence among women whose tumor tissue is positive for the IGF-1 receptor. The study suggests that personalized diets based on molecular characteristics of primary tumors may be possible, but further research is needed.
Scientists have identified a new biomarker called Neuromedin U (NmU) that may help predict and overcome resistance to newer anti-cancer drugs for HER2 positive cancers. The discovery could lead to more effective treatment strategies and improved patient outcomes.
A comprehensive clinical trial found that SPECT/CT imaging detected significantly more sentinel lymph node involvement with various types of cancers, including melanoma, breast carcinoma, and pelvic malignancies. This improved imaging technique has the potential to alter surgical planning and improve patient outcomes.
A new therapy that combines chemotherapy with radiounclide treatment has shown promising results in slowing or stopping the progression of neuroendocrine cancer. In a study of 68 patients, the therapy resulted in stabilization or regression of the disease in 70% of cases, leading to improved patient survival rates.
Researchers have discovered that over-expression of Cripto-1 makes lung cancer cells resistant to erlotinib, a widely used targeted therapy. Blocking Cripto-1 signaling restored sensitivity to the drug in cell lines and animals, suggesting a potential reversal mechanism.
Recent Medicare data release reveals high payments to a few doctors, but experts caution that this does not necessarily indicate poor care. The data only shows the amount of care provided, not its appropriateness, and may be influenced by factors such as specialty and geography.